@article{JTD12967,
author = {Arik Bernard Schulze and Lars Henning Schmidt},
title = {PD-1 targeted Immunotherapy as first-line therapy for advanced non-small-cell lung cancer patients},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {4},
year = {2017},
keywords = {},
abstract = {The better understanding of interactions between tumor and immune system (e.g., tumor-associated upregulation of PD-L1 to induce checkpoint for cytotoxic lymphocytes; Figure 1A) gave rise to the development of immune modulating therapies.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/12967}
}